Medicare Enrolled
Dr. Ghassan Nemri, M.D.
Anesthesiology · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nemri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nemri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nemri
Dr. Ghassan Nemri is an anesthesiology specialist in Spokane, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nemri performed 16,238 Medicare services across 1,694 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nemri received a total of $4,630 from 20 pharmaceutical and/or device companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nemri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in WA
$4,630 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,238
Medicare services
Top 0% in WA for anesthesiology
1,694
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~812 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging, lower concentration | 12,350 | $0 | $0 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
835 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
680 | $0 | $1 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
440 | $60 | $250 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
238 | $110 | $235 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
221 | $0 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
213 | $61 | $178 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
125 | $37 | $125 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
111 | $233 | $508 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
83 | $8 | $75 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
82 | $335 | $887 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
82 | $189 | $489 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
81 | $146 | $400 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
79 | $76 | $205 |
| Injection, fentanyl citrate, 0.1 mg | 78 | $1 | $12 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
69 | $150 | $322 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
63 | $203 | $594 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $90 | $253 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
50 | $48 | $130 |
| Behavioral health care management, 20+ minutes This service involves clinical staff time directed by a healthcare professional to manage behavioral health conditions. It requires at least 20 minutes of dedicated clinical staff time. |
49 | $30 | $85 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
47 | $85 | $236 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $104 | $327 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
34 | $3 | $7 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
29 | $195 | $409 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
23 | $203 | $594 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
22 | $177 | $494 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $18 | $46 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
17 | $330 | $879 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
17 | $196 | $519 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,630
Total received (2018-2024)
Avg $772/year across 6 years
Top 7% in WA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,630 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$366
2023
$408
2021
$12
2020
$2,492
2019
$426
2018
$926
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$207
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$124
Nevro Corp.
$22
ABBVIE INC.
$13
Top 3 companies account for 96.4% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$2,499
Daiichi Sankyo Inc.
$458
Collegium Pharmaceutical, Inc.
$452
ABBVIE INC.
$213
BioDelivery Sciences International, Inc.
$165
Takeda Pharmaceuticals U.S.A., Inc.
$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$163
PFIZER INC.
$152
Averitas Pharma Inc.
$88
Pernix Therapeutics Holdings, Inc.
$48
AstraZeneca Pharmaceuticals LP
$45
Purdue Pharma L.P.
$33
Assertio Therapeutics, Inc.
$33
Novartis Pharmaceuticals Corporation
$28
Boston Scientific Corporation
$20
Teva Pharmaceuticals USA, Inc.
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$15
Allergan Inc.
$14
Flexion Therapeutics, Inc.
$13
Zyla Life Sciences
$11
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Amitiza · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · Gralise · LUCEMYRA · LYRICA · MOVANTIK · Morphabond ER · Movantik · QUTENZA · RELISTOR · RINVOQ · SKYRIZI · SPECTRA WAVEWRITER · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · XTAMPZA · ZOHYDRO ER · ZORVOLEX · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for anesthesiology in WA.
Geographic Context
Anesthesiologists within 10 mi
130
Per 100K population
23.9
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
6.1 mi
6.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nemri is a mixed practice specialist, with above-average Medicare volume (top 0% in WA), with low-engagement industry engagement in the top 7% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nemri experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Nemri performed 12,350 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nemri receive payments from pharmaceutical companies?
Yes. Dr. Nemri received a total of $4,630 from 20 companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nemri's costs compare to other anesthesiologists in Spokane?
Dr. Nemri's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nemri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Spokane
Browse anesthesiologists in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in WA
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in WA
Which WA anesthesiologists receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology